INAB Archived Articles
IN8bio, Inc (NASDAQ:INAB): Pioneering Innovative Gamma-Delta T Cell Therapies in Oncology
Published on March 13, 2025
In8bio, Inc. (NASDAQ:INAB): Narrowing Focus to Drive Value with Innovative Gamma-Delta T Cell Therapies
Published on November 17, 2024
IN8BIO, INC.: A PROMISING GAMMA-DELTA T CELL THERAPY COMPANY POISED FOR GROWTH
Published on September 24, 2024